New wrinkle treatment could smooth frown lines without mixing
NCT ID NCT07321834
First seen Jan 09, 2026 · Last updated May 10, 2026 · Updated 23 times
Summary
This study tests a new liquid form of botulinum toxin (AI-09) that is ready to use without mixing. It aims to reduce moderate to severe frown lines between the eyebrows in adults aged 20 to 70. The treatment is injected directly into the skin, and researchers will check how well it works and if it is safe over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLABELLAR LINES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Clinical and Cosmetic Research
Aventura, Florida, 33180, United States
-
Delricht Research
New Orleans, Louisiana, 70115, United States
-
Research Institute of the Southeast, Inc.
West Palm Beach, Florida, 33401, United States
-
Research Your Health
Plano, Texas, 75093, United States
-
Tennessee Clinical Research Center
Nashville, Tennessee, 37215, United States
Conditions
Explore the condition pages connected to this study.